Welcome to our dedicated page for Credo Technology Group Holding SEC filings (Ticker: CRDO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Credo Technology Group Holding's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Credo Technology Group Holding's regulatory disclosures and financial reporting.
Credo Technology Group Holding (NASDAQ: CRDO) filed a Form 4 disclosing that director Lip-Bu Tan, through Walden Technology Ventures Investments II L.P., sold a total of 171,473 ordinary shares on 16 June 2025 across four tranches at weighted-average prices ranging from $76.6506 to $79.1236.
The transactions generated approximately $13.3 million in gross proceeds and reduced Walden’s indirect holding from about 785,198 to 613,725 shares, a decline of roughly 22%. Tan also continues to hold 133,583 shares via the Lip-Bu Tan and Ysa Loo Trust, 39,736 shares through A&E Investment LLC, and 53,574 shares directly.
No derivatives were transacted and the filing does not indicate that the sales were executed under a Rule 10b5-1 trading plan. No other material changes or risk factors were disclosed.
Credo Technology Group Chief Technology Officer and Director Cheng Chi Fung reported multiple sales of ordinary shares on June 16, 2025, executed through a pre-established Rule 10b5-1 trading plan from September 6, 2024.
The transactions involved the following sales from the Cheng Huang Family Trust:
- 1,500 shares at average price of $76.60
- 3,996 shares at average price of $77.94
- 34,644 shares at average price of $78.73
- 14,860 shares at average price of $79.30
Following these transactions, Fung maintains 119,350 shares held directly and 7,493,961 shares held indirectly through the Cheng Huang Family Trust. The trust transactions were executed at various price ranges, with all sales occurring between $76.05 and $79.66 per share.
Credo Technology Group Holding Ltd (CRDO) has received a Form 144 filing from Walden Technology Ventures II LP, an affiliate shareholder, indicating its intention to sell 54,297 common shares through Morgan Stanley Smith Barney on or about 18 June 2025 on the NASDAQ. At the 6 June market price implied by the filing, the transaction is valued at approximately $4.69 million.
The filing also discloses that the same shareholder has already sold 350,000 common shares during the past three months for aggregate gross proceeds of $26.7 million. Combining the completed and proposed transactions, Walden’s total share disposition during the period would reach 404,297 shares, equivalent to roughly 0.24 % of CRDO’s 169.8 million shares outstanding. The shares being sold were originally acquired directly from the issuer on 8 December 2017 via a private transaction for cash.
Because Form 144 filings merely provide advance notice of potential sales and do not guarantee execution, actual market impact will depend on whether the sales occur and the prevailing trading liquidity. Nonetheless, continued divestment by a venture-capital backer can signal portfolio rebalancing or profit-taking and may exert modest selling pressure. Given the limited percentage of outstanding shares involved, dilution is not an issue, but the filing may influence short-term sentiment toward CRDO’s stock.
Credo Technology Group (CRDO) – Form 4 Insider Transaction: Director Clyde Hosein disclosed the sale of 2,000 ordinary shares on 06/17/2025 at an average price of $78.4869 per share. Following the transaction, Hosein directly owns 18,761 shares of CRDO. No derivative security activity or additional transactions were reported. The filing was signed by attorney-in-fact James Laufman on 06/18/2025.